Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.
about
Intestinal microbiota in functional bowel disorders: a Rome foundation reportInflammation in irritable bowel syndrome: Myth or new treatment target?Diet in irritable bowel syndromeEndocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome.Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients.Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndromeStomach antral endocrine cells in patients with irritable bowel syndrome.From cytokines to toll-like receptors and beyond - current knowledge and future research needs in irritable bowel syndrome.Lessons Learnt from Post-Infectious IBS.Enteroendocrine cells express functional Toll-like receptorsRecent developments in the pathophysiology of irritable bowel syndrome.Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndromeLong-term sensitization of mechanosensitive and -insensitive afferents in mice with persistent colorectal hypersensitivity.Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalitiesIrritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.JCM-16021, a Chinese Herbal Formula, Attenuated Visceral Hyperalgesia in TNBS-Induced Postinflammatory Irritable Bowel Syndrome through Reducing Colonic EC Cell Hyperplasia and Serotonin Availability in RatsIrritable Bowel Syndrome: Peripheral Mechanisms and Therapeutic ImplicationsIrritable bowel syndrome: diagnosis and pathogenesis.High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitisEnteroendocrine cells: a review of their role in brain-gut communicationThe effect and mechanism of electroacupuncture at LI11 and ST37 on constipation in a rat model.Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndromeEndocrine cells in the ileum of patients with irritable bowel syndrome.Asian consensus on irritable bowel syndrome.Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome.Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.Is irritable bowel syndrome an organic disorder?Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment.Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome.Recent advances in the diagnosis of irritable bowel syndrome.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.Emerging treatments in Neurogastroenterology: Perspectives of guanylyl cyclase C agonists use in functional gastrointestinal disorders and inflammatory bowel diseases.The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.Heterogeneity of enterochromaffin cells within the gastrointestinal tract.From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
P2860
Q24631357-48426D87-4933-482F-ADBA-543B2D1D6959Q26768545-08C0E8A8-AD2F-4DFB-A07F-591C0BF67FD0Q26824367-7BD14A64-5D30-47D3-8A91-FCD3B31B91D3Q33625633-7997E1D3-1AA5-49DF-AFA4-4BF52E451A4BQ33890272-25D7409C-0B9E-46D6-B4E0-891E44CC5C16Q33987389-F7421192-7D08-415E-B126-1452F393E8C9Q34105187-55E034F5-17DA-4C0B-A250-912A2E0EA0E0Q34121823-E2FCA210-DCE0-4319-98B8-C4FA8534C99BQ34298260-B0BF6CF5-4169-4CCE-9ABE-DE5A751DC4CBQ35176122-9757B0B7-41D3-4B03-BBAF-8DC85356F9D2Q35467713-CAD2AAF1-DA0A-4E4C-8CBF-48EDAA1C593CQ35689193-97770463-81AB-4ADA-B6DE-E5E5F0A04237Q35837381-BF2C9B23-E4E0-48DA-9250-67163BF9FAEEQ35900869-EA700201-BA1E-44BC-A262-F0D09C061628Q35992392-38FCA583-4856-4306-9EB4-01B7F35E02C0Q35994064-29C4B4E6-EE59-4FF2-A7E2-4A53BC28837CQ36036768-2B1DACEF-1090-48E1-A046-6E7FFE117AD9Q36207200-8B4B23E5-3188-4D47-BED4-38F55807BF6DQ36310403-BB268D43-345E-4E31-B1BE-7A5198070E7AQ36395349-7342384E-1759-4B02-946B-A712937577A5Q36828610-04C7F5F2-18CE-4008-8FE0-1D53FFFEBF34Q37085603-2D981574-BC2F-4110-B169-F20834CF79F5Q37204274-2693E590-EBAC-4425-9A01-F30E573EC413Q37617989-35F7CBDC-EEAF-48FD-897B-63752A884C99Q37769278-067D3DFD-45AE-4D97-B7EF-C3FA89015519Q38014500-BF502BE6-53F5-47E5-80DD-E9D2DD8EDA83Q38052154-019D4866-9791-49BA-8D22-BF2E3660F1CFQ38191561-274E3075-14B9-4296-A974-CE7E63FB9523Q38192048-ACA27CD1-1EDA-4576-AE37-7941557693BBQ38193901-B9734C93-7926-42B6-92A3-3CCCFDB40EF6Q38545062-E550CCC5-79BF-49A7-830D-4A4B221C9F77Q38765085-F8BC0AD7-6B06-4076-AAC5-EB0CF6B38BFBQ38810529-051C076F-E027-4EE0-9147-880A2353DEC9Q39012302-BD1003A6-AB1E-4149-BF34-3F587BA22C81Q39031805-052A6FE1-74AA-47D8-9F4B-41760EC26EAFQ39293049-CB7BE310-2D24-4C97-9193-C481BB1B6B56Q39376100-77CC42D0-F158-4A6E-9C30-29D90E64EAB6Q41208488-BD90305C-68D7-402F-BA29-8278C34F3FFDQ42177644-D58FF908-5D27-49B9-830C-247087D3E959Q42230752-A6868352-3FE6-4078-BC15-4AF02864018C
P2860
Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@en
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@nl
type
label
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@en
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@nl
prefLabel
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@en
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@nl
P2093
P2860
P1476
Enteroendocrine cell counts co ...... nant irritable bowel syndrome.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2982.2006.00771.X
P577
2006-07-01T00:00:00Z